Paul A. Sobotka

11.4k total citations · 3 hit papers
83 papers, 7.4k citations indexed

About

Paul A. Sobotka is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul A. Sobotka has authored 83 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Cardiology and Cardiovascular Medicine, 23 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul A. Sobotka's work include Blood Pressure and Hypertension Studies (33 papers), Heart Rate Variability and Autonomic Control (32 papers) and Heart Failure Treatment and Management (14 papers). Paul A. Sobotka is often cited by papers focused on Blood Pressure and Hypertension Studies (33 papers), Heart Rate Variability and Autonomic Control (32 papers) and Heart Failure Treatment and Management (14 papers). Paul A. Sobotka collaborates with scholars based in United States, United Kingdom and Australia. Paul A. Sobotka's co-authors include Henry Krum, Markus P. Schlaich, Murray Esler, Roland E. Schmieder, Michael Böhm, Felix Mahfoud, Mitchell Saltzberg, Maria Rosa Costanzo, Mark E. Dunlap and Bradley A. Bart and has published in prestigious journals such as The Lancet, Circulation and Nature Communications.

In The Last Decade

Paul A. Sobotka

80 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

2010 1.4k citations Murray Esler, Henry Krum et al. The Lancet profile →
Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure

2007 716 citations Maria Rosa Costanzo, Maya Guglin et al. Journal of the American College of Cardiology profile →
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study

2013 429 citations Henry Krum, Markus P. Schlaich et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul A. Sobotka United States	39	6.0k	1.2k	1.2k	904	861	83	7.4k
Junichiro Hashimoto Japan	48	7.0k 1.2×	904 0.7×	1.6k 1.4×	786 0.9×	408 0.5×	178	8.5k
Satoshi Hoshide Japan	50	8.1k 1.4×	779 0.6×	1.9k 1.6×	1.3k 1.4×	336 0.4×	373	10.7k
Kazuyuki Shimada Japan	53	9.1k 1.5×	1.1k 0.9×	2.7k 2.3×	1.4k 1.5×	296 0.3×	335	12.3k
Klaus K. Witte United Kingdom	48	5.3k 0.9×	865 0.7×	986 0.8×	646 0.7×	439 0.5×	316	9.3k
Giuseppe Mancia Italy	56	9.5k 1.6×	740 0.6×	2.7k 2.3×	846 0.9×	1.0k 1.2×	210	11.7k
Anton H. van den Meiracker Netherlands	48	3.9k 0.7×	950 0.8×	1.6k 1.4×	356 0.4×	249 0.3×	218	7.9k
Gino Seravalle Italy	47	6.5k 1.1×	356 0.3×	1.1k 0.9×	671 0.7×	378 0.4×	184	8.8k
Hirofumi Tomiyama Japan	42	6.0k 1.0×	1.5k 1.3×	1.3k 1.1×	304 0.3×	284 0.3×	185	8.1k
Gert A. van Montfrans Netherlands	41	3.4k 0.6×	354 0.3×	1.5k 1.3×	335 0.4×	524 0.6×	142	5.9k
Paul L. Padfield United Kingdom	33	3.4k 0.6×	761 0.6×	1.6k 1.3×	436 0.5×	401 0.5×	119	6.0k

Countries citing papers authored by Paul A. Sobotka

Since Specialization

Citations

This map shows the geographic impact of Paul A. Sobotka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Sobotka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Sobotka more than expected).

Fields of papers citing papers by Paul A. Sobotka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Sobotka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Sobotka. The network helps show where Paul A. Sobotka may publish in the future.

Co-authorship network of co-authors of Paul A. Sobotka

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Sobotka. A scholar is included among the top collaborators of Paul A. Sobotka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Sobotka. Paul A. Sobotka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sheikh, Abu Baker, Paul A. Sobotka, Ishan Garg, et al.. (2023). Blood Pressure Variability in Clinical Practice: Past, Present and the Future. Journal of the American Heart Association. 12(9). e029297–e029297. 36 indexed citations

Sun, Ningling, Junbo Ge, Hong Jiang, et al.. (2022). Rationale and Design of Sympathetic Mapping/Ablation of Renal Nerves Trial (SMART) for the Treatment of Hypertension: a Prospective, Multicenter, Single-Blind, Randomized and Sham Procedure-Controlled Study. Journal of Cardiovascular Translational Research. 16(2). 358–370. 6 indexed citations

Fudim, Marat, Piotr Ponikowski, Daniel Burkhoff, et al.. (2021). Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerations. European Journal of Heart Failure. 23(7). 1076–1084. 29 indexed citations

Shochat, Michael, Marat Fudim, Avraham Shotan, et al.. (2018). Prediction of Readmissions and Mortality in Patients with Heart Failure: Lessons from the IMPEDANCE-HF Extended Trial. ESC Heart Failure. 5(5). 788–799. 22 indexed citations

Ott, Christian, Rolf Janka, Axel Schmid, et al.. (2013). Vascular and Renal Hemodynamic Changes after Renal Denervation. Clinical Journal of the American Society of Nephrology. 8(7). 1195–1201. 45 indexed citations

Niewiński, Piotr, Zoar J. Engelman, Marat Fudim, et al.. (2013). Clinical Predictors and Hemodynamic Consequences of Elevated Peripheral Chemosensitivity in Optimally Treated Men With Chronic Systolic Heart Failure. Journal of Cardiac Failure. 19(6). 408–415. 43 indexed citations

McBryde, Fiona D., Ana P. Abdala, Emma B. Hendy, et al.. (2013). The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension. Nature Communications. 4(1). 2395–2395. 198 indexed citations

Burchell, Amy E., Paul A. Sobotka, Emma C. Hart, Angus K. Nightingale, & Mark E. Dunlap. (2013). Chemohypersensitivity and Autonomic Modulation of Venous Capacitance in the Pathophysiology of Acute Decompensated Heart Failure. Current Heart Failure Reports. 10(2). 139–146. 24 indexed citations

Krum, Henry, Markus P. Schlaich, Paul A. Sobotka, et al.. (2012). TCT-12 Long-term Follow-up of Catheter-based Renal Denervation For Resistant Hypertension Confirms Durable Blood Pressure Reduction. Journal of the American College of Cardiology. 60(17). B3–B3. 15 indexed citations

10.

Ukena, Christian, Felix Mahfoud, Ingrid Kindermann, et al.. (2011). Cardiorespiratory Response to Exercise After Renal Sympathetic Denervation in Patients With Resistant Hypertension. Journal of the American College of Cardiology. 58(11). 1176–1182. 99 indexed citations

11.

Krum, Henry, Markus P. Schlaich, Paul A. Sobotka, et al.. (2011). Novel procedure- and device-based strategies in the management of systemic hypertension. European Heart Journal. 32(5). 537–544. 29 indexed citations

12.

Schlaich, Markus P., Paul A. Sobotka, Henry Krum, et al.. (2009). Renal Denervation as a Therapeutic Approach for Hypertension. Hypertension. 54(6). 1195–1201. 178 indexed citations

13.

Dahle, Thom, Paul A. Sobotka, & Andrew Boyle. (2008). A Practical Guide for Ultrafiltration in Acute Decompensated Heart Failure. Congestive Heart Failure. 14(2). 83–88. 12 indexed citations

14.

Costanzo, Maria Rosa, Maya Guglin, Mitchell Saltzberg, et al.. (2007). Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure. Journal of the American College of Cardiology. 49(6). 675–683. 716 indexed citations breakdown →

15.

Boyle, Andrew & Paul A. Sobotka. (2006). Redefining the Therapeutic Objective in Decompensated Heart Failure: Hemoconcentration as a Surrogate for Plasma Refill Rate. Journal of Cardiac Failure. 12(4). 247–249. 55 indexed citations

16.

Bart, Bradley A., Andrew Boyle, Alan J. Bank, et al.. (2005). Ultrafiltration Versus Usual Care for Hospitalized Patients With Heart Failure. Journal of the American College of Cardiology. 46(11). 2043–2046. 280 indexed citations

17.

Costanzo, Maria Rosa, et al.. (2005). Early Ultrafiltration in Patients With Decompensated Heart Failure and Diuretic Resistance. Journal of the American College of Cardiology. 46(11). 2047–2051. 171 indexed citations

18.

Mendis, Shanthi, et al.. (1995). Breath pentane and plasma lipid peroxides in ischemic heart disease. Free Radical Biology and Medicine. 19(5). 679–684. 46 indexed citations

19.

Sobotka, Paul A., Ramesh I. Patel, Robert H. Wagner, et al.. (1993). Abnormal Ambulatory Left Ventricular Ejection Fraction in Heart Transplant Arteriopathy. Clinical Nuclear Medicine. 18(12). 1059–1062.

20.

Skosey, John L., et al.. (1991). High breath pentane concentrations during acute myocardial infarction. The Lancet. 337(8747). 933–935. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact